

iwNHL Session III: exploring the optimal management of R/R follicular lymphoma in an expanding treatment landscape
Nov 18, 2022
Laura Pasqualucci, MD, specializes in R/R follicular lymphoma. Topics include optimal management, combining therapies, sequencing therapies, and role of epigenetic alterations. Explore potential of epigenetic and immunotherapies, CD47 engagement/blocking, and EZH2 inhibition. Also discuss CD58 expression, antigen presentation, and challenges in treating follicular lymphoma.
Chapters
Transcript
Episode notes
1 2 3 4
Introduction
00:00 • 5min
Exploring the Potential of Epigenetic and Immunotherapies for Follicular Lymphoma
04:49 • 2min
Exploring the Potential of EZH2 Inhibition and CD58 Expression in the Treatment of Follicular Lymphoma
06:45 • 2min
Exploring CD58 expression, antigen presentation, and the microenvironment in follicular lymphoma
08:41 • 3min